top of page
Busy Office

Kendall Investor Relations Leadership

Kendall IR is an investor relations firm providing senior-level strategic and operational IR services to biotech companies. We are former biotech senior executives with decades of experience in R&D, corporate development, commercial operations, finance, and investor relations, serving fellow biotech executives.

We understand science, value creation, and how investors assess biotech investment opportunities. Our backgrounds, coupled with our relationships and credibility in the biotech investment community enable us to provide thoughtful, effective IR service that maximizes long term value.


Carlo Tanzi, Ph.D.

Principal & Founder


Adam Bero, Ph.D

Managing Director

Sarah E Headshot_edited_edited.jpg

Sarah Ellinwood, Ph.D.

Senior Vice President

Tracy bio color_edited.jpg

Tracy Lessor, Ph.D., MBA

Senior Vice President

Photo for Bios (2)_edited_edited_edited.

Kim Smith

Senior Advisor


Wendy Gabel

Senior Advisor & Founding Member


Mark Breidenbach, Ph.D

Managing Director


Lauren Stival Hopfer

Senior Vice President


David Arkowitz

Senior Advisor

Interested in a career with Kendall Investor Relations?
bottom of page